Effects of age and disease duration on the glycaemic outcomes and safety of insulin glargine 300 U/ <scp>mL</scp> in people with type 2 diabetes in China: A post‐hoc analysis of the <scp>INITIATION</scp> study
20260 citationsJournal Articlehybrid Open Access
Field-Weighted Citation Impact: 0.00
Effects of age and disease duration on the glycaemic outcomes and safety of insulin glargine 300 U/ <scp>mL</scp> in people with type 2 diabetes in China: A post‐hoc analysis of the <scp>INITIATION</scp> study | Researchclopedia